Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gambiense Trypanosomiasis”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Not applicableWithdrawnNCT03394976
What this trial is testing

Prospective Evaluation of an RDT to Screen for Gambiense HAT and Diagnose P. Falciparum Malaria

Who this might be right for
Human African Trypanosomiasis
Foundation for Innovative New Diagnostics, Switzerland
Large-scale testing (Phase 3)Study completedNCT05256017
What this trial is testing

Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects

Who this might be right for
Trypanosomiasis, AfricanTrypanosoma Brucei Gambiense; InfectionSleeping Sickness
Drugs for Neglected Diseases 1,208
Not applicableStudy completedNCT03112655
What this trial is testing

Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: Early Test-of-cure

Who this might be right for
African TrypanosomiasisAfrican; Trypanosomiasis, WestSleeping Sickness; West African+1 more
Institut de Recherche pour le Developpement 88
Large-scale testing (Phase 3)Not Yet RecruitingNCT06356974
What this trial is testing

Stop Transmission of Gambiense Human African Trypanosomiasis (STROgHAT)

Who this might be right for
Human African Trypanosomiasis
Drugs for Neglected Diseases 2,500
Large-scale testing (Phase 3)Study completedNCT02169557
What this trial is testing

Efficacy and Safety of Fexinidazole in Patients With Stage 1 or Early Stage 2 Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open-label Cohort Study, plug-in to the Pivotal Study

Who this might be right for
Human African Trypanosomiasis (HAT)
Drugs for Neglected Diseases 230
Not applicableStudy completedNCT05466630
What this trial is testing

Prospective Evaluation of the Specificity of Serological Tests for Human African Trypanosomiasis

Who this might be right for
Human African TrypanosomiasisSleeping SicknessTrypanosoma Brucei Gambiense; Infection+1 more
Institut de Recherche pour le Developpement 1,095
Not applicableStudy completedNCT03356665
What this trial is testing

Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP2 Passive Case Detection

Who this might be right for
African TrypanosomiasesWest African; TrypanosomiasisSleeping Sickness; West African+1 more
Institut de Recherche pour le Developpement 10,700
Large-scale testing (Phase 3)Ended earlyNCT00489658
What this trial is testing

Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda

Who this might be right for
Trypanosomiasis, African
Epicentre 31
Large-scale testing (Phase 3)Study completedNCT03025789
What this trial is testing

Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage

Who this might be right for
Trypanosomiasis, AfricanSleeping SicknessTrypanosomiasis; Gambian
Drugs for Neglected Diseases 174
Large-scale testing (Phase 3)Study completedNCT03087955
What this trial is testing

Efficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. Gambiense

Who this might be right for
Trypanosomiasis, AfricanGambiense TrypanosomiasisSleeping Sickness
Drugs for Neglected Diseases 208
Testing effectiveness (Phase 2)Study completedNCT00802594
What this trial is testing

A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis

Who this might be right for
Trypanosomiasis, African
Immtech Pharmaceuticals, Inc 30
Large-scale testing (Phase 3)Ended earlyNCT00330148
What this trial is testing

Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis

Who this might be right for
Trypanosomiasis, African
Epicentre 435
Large-scale testing (Phase 3)Study completedNCT02184689
What this trial is testing

Efficacy and Safety of Fexinidazole in Children at Least 6 Years Old and Weighing Over 20 kg With Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open Study, plug-in to the Pivotal Study

Who this might be right for
Human African Trypanosomiasis (HAT)
Drugs for Neglected Diseases 125
Post-approval studies (Phase 4)Study completedNCT00906880
What this trial is testing

Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic Phase

Who this might be right for
Human African Trypanosomiasis
Drugs for Neglected Diseases 630
Large-scale testing (Phase 3)Study completedNCT01685827
What this trial is testing

Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2

Who this might be right for
Human African Trypanosomiasis (HAT)Sleeping Sickness
Drugs for Neglected Diseases 394
Testing effectiveness (Phase 2)Study completedNCT00803933
What this trial is testing

Trial of DB289 for the Treatment of Stage I African Trypanosomiasis

Who this might be right for
African Trypanosomiasis
Immtech Pharmaceuticals, Inc 111
Large-scale testing (Phase 3)Active Not RecruitingNCT05433350
What this trial is testing

Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients

Who this might be right for
Trypanosomiasis, AfricanTrypanosoma Brucei Gambiense; InfectionSleeping Sickness
Drugs for Neglected Diseases 35
Not applicableStudy completedNCT04099628
What this trial is testing

Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP3 Post Elimination Monitoring

Who this might be right for
Human African TrypanosomiasisSleeping SicknessTrypanosoma Brucei Gambiense; Infection+3 more
Institut de Recherche pour le Developpement 13,747
Large-scale testing (Phase 3)Study completedNCT00146627
What this trial is testing

Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis

Who this might be right for
Trypanosomiasis, African
Drugs for Neglected Diseases 280